Premia中銀香港沙特伊斯蘭國債ETF(03478.HK)今掛牌
港交所(00388.HK)公布,Premia中銀香港沙特伊斯蘭國債ETF港元櫃台單位(03478.HK)及美元櫃台單位(09478.HK)今日(29日)起在交易所買賣及獲准列入認可賣空指定證券。有關交易所參與者已獲發證券莊家許可證,於同日開始生效,為上述交易所買賣基金提供莊家活動。
每手交易單位為50單位計,Premia中銀香港沙特伊斯蘭國債ETF港元櫃台單位現報82.56元,成交2,050股,涉資逾16.9萬元,一手入場費4,128元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.